AK

Abhijeet Kumar

Active Director Director DIN 11320544
DIN 11320544 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value •••• Premium profile

About Abhijeet Kumar

Data last updated:

Abhijeet Kumar is a Director at Izec Life Sciences Private Limited (since 2025). The company operates in Pharma. Izec Life Sciences Private Limited reported revenue of ₹24.7 Lakh (FY 2025).

DIN 11320544
Primary Designation Director
Industry Pharma
First Appointment 29 Oct 2025
Largest company Izec Life Sciences Private Limited · ₹24.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Izec Life Sciences Private Limited U24110BR2021PTC053403
Director29 Oct 2025₹24.7 Lakh (FY 2025)Active

Board colleagues of Abhijeet Kumar

Directorship timeline

Open interactive timeline →
Izec Life Sciences Private Limited
Premium access

Shareholding and investment profile for Abhijeet Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijeet Kumar

Abhijeet Kumar currently holds 1 directorship: Izec Life Sciences Private Limited (Director, since 29 Oct 2025, revenue ₹24.7 Lakh (FY 2025)).

Abhijeet Kumar was first appointed on 29 Oct 2025 as Director at Izec Life Sciences Private Limited.

The current boards of Abhijeet Kumar's companies include Ajay Kumar (Izec Life Sciences Private Limited), Drawesh Kumar Jha (Izec Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available